Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
Press Releases
Events
Tigermed Insights
Resource Library
Sustainability & ESG Report
ESG Management
Corporate Responsibility
Corporate Video
We are committed to supporting our clients in their clinical development in the best possible way.
Preclinical
Early Phase
Phase II-III Clinical
Post-Marketing
Real World Study
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Site Management (SMO)
Subject Recruitment
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
Medical Imaging
Pharmacovigilance
Medical Translation
Quality Assurance
GMP Consulting
Central Laboratories
Functional Service Provider (FSP)
EDC System
Call Center
Oncology
Infectious Diseases
Hematology
Cardiovascular
Endocrinology
Rheumatology
Central Nervous System
Gastroenterology
Ophthalmology
Talent Development
Enjoy Your Life with Tigermed
Join Tigermed
Discover our offices across Asia, US, Europe, Latin America and Africa.
Career Opportunities
Explore your career opportunities worldwide with Tigermed.
Corporate Governance
Financial Reports & Presentations
Announcements
Prospectus
Investor Contact
Tigermed 2023 Interim Results Presentation
View Tigermed 2023 Interim Results Presentation
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Business Enquiry / RFP
Media & Investors Enquiry
Compliance Concern
Give Us Your Feedback
Let us know how we can help with your healthcare innovation.
Submit media or investor related enquiries to us.
Investors
Nov 02, 2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Read more
Oct 27, 2023
2023 THIRD QUARTERLY REPORT
Oct 16, 2023
DATE OF BOARD MEETING
Oct 09, 2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Sep 27, 2023
Notification Letter and Request Form to Non-Registered Holders
2023 INTERIM REPORT
Sep 05, 2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Aug 28, 2023
SUPPLEMENTAL INFORMATION IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2022
Aug 25, 2023
Aug 15, 2023
Aug 02, 2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Jul 06, 2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Jun 26, 2023
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2022 (UPDATED)
CHANGE OF PAYMENT DATE OF FINAL DIVIDEND OF H SHARES
Jun 05, 2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.